Home > Drugs A-Z > Ready Foundation

Ready Foundation (Bare Escentuals Beauty Inc.)

Available Formats

Dosage Form Package Information Links
POWDER 14 g in 1 TRAY (98132-163-08) Label Information

Complete Ready Foundation Information

  • SPL UNCLASSIFIED SECTION

    Drug Facts


  • ACTIVE INGREDIENT

    Active ingredient(s) Purpose
    Titanium dioxide 11.0% Sunscreen
    Zinc oxide 18.0% Sunscreen

  • Uses

    • helps prevent sunburn
    • if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

  • Warnings

    For external use only

    Do not use on damaged or broken skin

    When using this product keep out of eyes. Rinse with water to remove.

    Stop use and ask a doctor if rash occurs

    Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.


  • Directions

    For sunscreen use:

    • apply liberally 15 minutes before sun exposure
    • use a water resistant sunscreen if swimming or sweating
    • reapply at least every 2 hours
    • children under 6 months: ask a doctor
    • Sun protection measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF of 15 or higher and other sun protection measures including:
      • limit time in the sun, especially from 10 a.m. – 2 p.m.
      • wear long-sleeve shirts, pants, hats, and sunglasses

  • Inactive ingredients

    boron nitride, octyldodecyl stearoyl stearate, glycerin, caprylic/capric triglyceride, magnesium silicate, silica, nylon-12, rosa canina fruit oil, jojoba esters, algae extract, alaria esculenta extract, humic acids, lecithin, betaine, mannitol, stearic acid, diatomaceous earth, zinc sulfate, chlorphenesin. may contain: mica, titanium dioxide, iron oxides, bismuth oxychloride.


  • Other information

    Protect this product from excessive heat and direct sun


  • Questions or comments?

    Call toll free 1-888-795-4747


  • SPL UNCLASSIFIED SECTION

    Dist. by Bare Escentuals Beauty, Inc., SF, CA 94105 USA


  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R110

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R110

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R170

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R170

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R130

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R130

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R230

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R230

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R150

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R150

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R210

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R210

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R250

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R250

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R270

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R270

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R310

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R310

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R350

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R350

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R330

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R330

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R410

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R410

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R370

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R370

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R450

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R450

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R430

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R430

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R470

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R470

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R550

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R550

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R570

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R570

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R510

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R510

  • PRINCIPAL DISPLAY PANEL - 14 g Carton - R530

    bareMinerals®

    net wt 14 g / 0.49 oz.

    Principal Display Panel - 14 g Carton - R530

  • INGREDIENTS AND APPEARANCE
    READY FOUNDATION   FAIR
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-163
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-163-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   FAIRLY LIGHT
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-164
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-164-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   GOLDEN FAIR
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-165
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-165-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   LIGHT
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-166
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-166-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   FAIRLY MEDIUM
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-167
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-167-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   MEDIUM
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-168
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-168-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   MEDIUM BEIGE
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-169
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-169-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   GOLDEN MEDIUM
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-170
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-170-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   MEDIUM TAN
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-171
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-171-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   TAN
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-172
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-172-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   WARM TAN
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-173
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-173-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   GOLDEN TAN
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-174
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-174-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   DARK
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-175
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-175-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   MEDIUM DARK
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-176
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-176-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   WARM DARK
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-177
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-177-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   GOLDEN DARK
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-178
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-178-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   MEDIUM DEEP
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-179
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-179-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   DEEPEST DEEP
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-180
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-180-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   GOLDEN DEEP
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-181
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-181-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    READY FOUNDATION   WARM DEEP
    titanium dioxide and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-182
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g  in 100 g
    Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    boron nitride (UNII: 2U4T60A6YD)  
    octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)  
    glycerin (UNII: PDC6A3C0OX)  
    medium-chain triglycerides (UNII: C9H2L21V7U)  
    magnesium silicate (UNII: 9B9691B2N9)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    nylon-12 (UNII: 446U8J075B)  
    rosa canina fruit oil (UNII: CR7307M3QZ)  
    alaria esculenta (UNII: EJ9JK8J58D)  
    betaine (UNII: 3SCV180C9W)  
    mannitol (UNII: 3OWL53L36A)  
    stearic acid (UNII: 4ELV7Z65AP)  
    diatomaceous earth (UNII: 2RF6EJ0M85)  
    zinc sulfate (UNII: 89DS0H96TB)  
    chlorphenesin (UNII: I670DAL4SZ)  
    mica (UNII: V8A1AW0880)  
    ferric oxide red (UNII: 1K09F3G675)  
    bismuth oxychloride (UNII: 4ZR792I587)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:98132-182-08 14 g in 1 TRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part352 06/01/2012
    Labeler - Bare Escentuals Beauty Inc. (087008363)